SLO-BID 100 Strength
Active ingredient(s) See footnote 8 : Strength THEOPHYLLINE : 100 MG · DIN 01926586 · AVENTIS PHARMA INC 2905 Place Louis-R. Renaud Laval Quebec Canada H7V 0A3
Health Canada status: CANCELLED POST MARKET
What is SLO-BID 100?
SLO-BID 100 Strength contains Active ingredient(s) See footnote 8 : Strength THEOPHYLLINE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 01926586, held by AVENTIS PHARMA INC 2905 Place Louis-R. Renaud Laval Quebec Canada H7V 0A3, supplied as Capsule (Sustained-Release) for Oral administration. Health Canada currently lists it as cancelled post market, status dated 22-Jul-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 01926586 |
|---|---|
| Brand name | SLO-BID 100 |
| Generic / active ingredient | Active ingredient(s) See footnote 8 : Strength THEOPHYLLINE : 100 MG |
| Manufacturer | AVENTIS PHARMA INC 2905 Place Louis-R. Renaud Laval Quebec Canada H7V 0A3 |
| Strength | Strength |
| Dosage form | Capsule (Sustained-Release) |
| Route of administration | Oral |
| Schedule | PRESCRIPTION |
| ATC code | R03DA04 THEOPHYLLINE |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 22-Jul-2003 |
| Original market date | 1987-12-31 |
What can be used instead?
Other Canadian products sharing ATC code R03DA04 THEOPHYLLINE. 6 of 39 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AA-THEO LA | 100 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | DIN 00692689 |
| AA-THEO LA | 200 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | DIN 00692697 |
| AA-THEO LA | 300 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | DIN 00692700 |
| ELIXIR DE THEOPHYLLINE | 80 MG / 15 ML | ELIXIR | LABORATOIRE ATLAS INC | MARKETED | DIN 00627410 |
| THEO ER | 400 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | DIN 02360101 |
| THEO ER | 600 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | DIN 02360128 |
| APO-THEO ER | 400 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | APPROVED | DIN 02358395 |
| APO-THEO ER | 600 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | APPROVED | DIN 02358409 |
| PMS-THEOPHYLLINE ELIXIR | 80 MG / 15 ML | ELIXIR | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 00575151 |
| PULMOPHYLLINE ELX | 80 MG / 15 ML | ELIXIR | LABORATOIRE RIVA INC. | DORMANT | DIN 00466409 |
Who else supplies THEOPHYLLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. THEOPHYLLINE appears in 1365 registered pack listings across 7 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.